Welcome to Medivizor!

You're browsing our sample library. Feel free to continue browsing. You can also sign up for free to receive medical information specific to your situation.

Posted by on Jun 29, 2013 in Breast cancer | 0 comments

In a nutshell

This study tested the effect of complete axillary lymph node removal, on survival without recurrence of the cancer (called disease free survival or DFS) in patients with breast cancer. 

Some background

Lymph nodes are small organs which are part of the immune system. They filter fluid called lymph. Lymph can be thought of as the sewer system of the body. It drains fluid from tissues and from in between the cells. When cancer is detected in the body, the first lymph node draining the area of the cancer is checked to see if the cancer has spread to it. This is called the sentinel lymph node. In the case of breast cancer, these lymph nodes are found in the axillary (arm pit) region. A biopsy (microscopic examination of a tissue sample taken with a needle or by small surgery) of the lymph nodes indicates if the patient's cancer has spread. Usually, if cancer cells are found in the sentinel node, all axillary lymph nodes are removed. This surgery is referred to as complete axillary lymph node dissection. It has been suggested though, that in patients showing only a limited involvement of the sentinel node, this complete dissection might be considered as overtreatment.

Methods & findings

This phase III trial included 931 patients with an early stage breast cancer. All patients showed minimal involvement of the sentinel lymph node when a biopsy was performed. 464 patients were randomly chosen to receive a complete axillary lymph node dissection. The remaining 467 patients had only the sentinel nodes removed, but did not receive a complete axillary node dissection. Patients were followed for five years to check whether complete axillary node dissection affected prognosis.

Results showed that patients who did not undergo complete axillary node dissection had just as good an outcome as those who did. 5 years after surgery, DFS was 84.4% for patients in the group that underwent complete axillary node dissection, compared to 87.8% in the group that did not receive a complete dissection. In addition, 7 patients in the complete axillary node dissection group reported side effects such as damage to the nerves in the region related to the surgery itself. 

The bottom line

In this study, the complete removal of the axillary lymph nodes could be avoided in patients with minimal sentinel lymph node involvement.

The fine print

The results of this study are similar to previously published trials on the subject. This gives these results greater credibility. However, it should be noted that only patients with very limited (<2mm) involvement of the lymph nodes were included, and these results are relevant only to these patients.

What’s next?

Consult with your physician regarding the best surgical option for your situation.

Published By :

Lancet oncology

Date :

Mar 11, 2013

Original Title :

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01) a phase 3 randomised controlled trial

click here to get personalized updates